Volume and yield of screening colonoscopy at a tertiary medical center after change in Medicare reimbursement

Division of Gastroenterology & Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
The American Journal of Gastroenterology (Impact Factor: 10.76). 01/2003; 98(1):194-9. DOI: 10.1111/j.1572-0241.2003.07172.x
Source: PubMed


Starting July 1, 2001, Medicare began to reimburse for screening colonoscopy in asymptomatic adults older than 50 yr with no risk factors for colorectal cancer. We sought to determine the short-term impact of the change in Medicare reimbursement on the demand for and yield of screening colonoscopy at our tertiary institution.
Asymptomatic patients older than 50 referred for first screening colonoscopy after the change in Medicare reimbursement from July 1, 2001 to December 31, 2001 were compared with a similar cohort screened before Medicare coverage for a family history of cancer or polyps during the same months the previous year (July 1, 2000 to December 31, 2000). Patient demographics, number, size, location, and histology of polyps/cancers for these screening colonoscopies were collected.
A total of 1282 colonoscopies were performed in our institution from July 1, 2001 to December 31, 2001, 257 (20%) for screening. During the same months in the previous year, 121 of 938 colonoscopies (12.9%) were for screening (p < 0.01). This was a 55% increase in the percentage of colonoscopies performed for screening, and a 112% increase in the number of screening colonoscopies. Patients screened after the change in Medicare reimbursement were on average 5 yr older compared with patients of the previous year (62 +/- 10 [mean +/- SD] vs 56 +/- 9 yr; p < 0.01). A total of 61 screening colonoscopies (24%) performed after the change in Medicare reimbursement had adenomatous lesions, compared with 25 (21%) screened for family history (p = ns). The number of adenomas 10 mm or larger or cancers did not differ significantly between the two groups (17 in 2001 vs 12 in 2000; p = ns). Age of 65 or older was associated with detection of adenomatous lesions (OR = 1.7; 95% CI = 1.01-2.9013).
Since the change in Medicare reimbursement, there has been a significant increase in the number and proportion of colonoscopies performed for screening at our institution. Patients screened since this change are older, and the detection rate of neoplastic lesions is similar to those previously screened for a family history of colorectal cancer or polyps.

Download full-text


Available from: David G. Binion, Jun 15, 2015
  • Source
    • "In addition, our results suggest that among low- and middle- income groups, mandates seemed to have benefited higher-educated groups more than lower-educated, whereas education-related disparities in high income groups appear to have been reduced as a result of mandates. Even though we know of no prior study that has examined this association in a non-Medicare insured population of adults aged 50 to 64 years, our study findings are generally consistent with previous studies conducted among the elderly Medicare beneficiaries, showing positive effects of policy changes [21-24]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Several states in the US have passed laws mandating coverage of colorectal cancer (CRC) screening tests by health insurance plans. The impact of these state mandates on the use of colorectal cancer screening has not been evaluated among an age-eligible target population with access to care (i.e., health care insurance coverage). We collected information on state mandates implemented by December 31, 2008 and used data on insured adults aged 50 and 64 years from the Behavioral Risk Factor Surveillance System between 2002 and 2008 to classify individual-level exposure to state mandates for at least 1 year. Multivariate logistic regression models (with state- and year- fixed effects, and patient demographic and socioeconomic characteristics) were used to estimate the effect of state mandates on recent endoscopy screening (either flexible sigmoidoscopy or colonoscopy during the past year). From 1999-2008, twenty-two states in the US, including the District of Columbia passed comprehensive laws requiring health insurance coverage of CRC screening including endoscopy tests. Residence in states with CRC screening coverage mandates in place for at least 1 year was associated with a 1.4 percentage point increase in the probability of utilization of recent endoscopy (i.e., 17.5% screening rates in those with mandates versus 16.1% in those without, Adjusted OR = 1.10, 95% CI: 1.02-1.20, p = 0.02). The findings suggest a positive, albeit small, impact of state mandates on the use of recent CRC screening endoscopy among the target eligible population with health insurance. However, more research is needed to evaluate potential effects of mandates across health insurance types while including controls for other system-level factors (e.g. endoscopy and primary care capacity). National health insurance reform should strive towards a system that expands access to recommended CRC screening tests.
    Full-text · Article · Jan 2011 · BMC Health Services Research
  • Source
    • "The American College of Gastroenterology recommends colonoscopy as the preferred screening strategy for colorectal neoplasia [12]. Colonoscopy has emerged as the first-line imaging technique for investigation of the colon [13]. Over the years there have been many attempts to improve caecal intubation rates. "
    [Show abstract] [Hide abstract]
    ABSTRACT: a b s t r a c t Background and study aims: The use of an upper endoscope has been considered as a back-up method in case of incomplete caecal intubation. We compared caecal intubation rates between colonoscopic exam-inations done with a standard colonoscope and those in which a standard gastroscope was used, to deter-mine if routine colonoscopies could be performed with a gastroscope if no colonoscope is available. Patients and methods: A prospective comparative study, analyzing continuous data was designed to eval-uate the usefulness of a standard gastroscope in a group of outpatients with indication for colonoscopy in colorectal cancer screening. A total of 170 adult patients were randomly assigned to two similar study groups. All examinations were performed by a single endoscopist. Our primary end point was to achieve caecal intubation. Results: Successful caecal intubation was achieved in 162 patients that fulfilled our inclusion criteria, 83 patients in the colonoscope and 79 in the gastroscope group. Failure of caecal intubation was similar in male and female patients in both groups (p = 0.34). Caecal intubation failure rates were similar in both study groups. Conclusions: We used the gastroscope as a first line method for routine colonoscopies and found no sta-tistical difference between the colonoscope and gastroscope groups. If these results can be verified in lar-ger multicenter studies, it may be possible in the future, to work with only one endoscope for both upper and lower digestive tract examinations in small centers, particularly in developing countries.
    Preview · Article · Mar 2010 · Arab Journal of Gastroenterology
  • [Show abstract] [Hide abstract]
    ABSTRACT: With the increasing awareness and detection of gastrointestinal cancer, patients and physicians are asking what role diet plays in its development. The objective of this review is to provide a summary of the research to date in regards to nutrition and the prevention of gastrointestinal cancer. The gastrointestinal cancers that are addressed in this article include: esophageal cancer (squamous and adenocarcinoma), colorectal cancer, gastric cancer (adenocarcinoma), and pancreatic cancer. Based on the review of the best available literature, certain suggestions can be made to physicians and patients regarding nutritional prevention of gastrointestinal cancer.
    No preview · Article ·
Show more